ARONTIER ^Companies

The company's platform offers tools for drug discovery, the development of anti-CAF drugs, and genetic editing that uses data science-based bio information analysis, drug genomics, and screening technology which focuses on cancer vulnerable to cancer therapy, enabling the medical industry to avail effective drugs for incurable diseases with technology to improve human health and happiness.Arontier Company Profile: Valuation & Investors | PitchBookpitchbook.com/profiles/company/469432-00